首页> 外文OA文献 >High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial). : High-Dose peg-IFN and Ribavirin and IL28B in HCV nonresponders

【2h】

High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial). : High-Dose peg-IFN and Ribavirin and IL28B in HCV nonresponders

机译：无反应性丙型肝炎患者的大剂量聚乙二醇化干扰素-α和利巴韦林及其与IL-28B基因型的关系（SYREN试验）。：HCV无应答者中的大剂量PEG-IFN和利巴韦林和IL28B

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Chevaliez, Stéphane; Hézode, Christophe; Soulier, Alexandre; Costes, Bruno; Bouvier-Alias, Magali; Rouanet, Stéphanie; Foucher, Juliette; Bronowicki, Jean-Pierre; Tran, Albert; Rosa, Isabelle; Mathurin, Philippe; Alric, Laurent; Leroy, Vincent; Couzigou, Patrice; Mallat, Ariane; Charaf-Eddine, Mariem; Babany, Gérard; Pawlotsky, Jean-Michel;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. High-dose pegylated interferon-alpha and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial). [J] . Chevaliez S, Hezode C, Soulier A, Gastroenterology . 2011,第1期

机译：无反应丙型肝炎患者的大剂量聚乙二醇化干扰素-α和利巴韦林及其与IL-28B基因型的关系（SYREN试验）。
2. OL-002 Effect of high-dose ribavirin (RBV), Alinia (Nitazoxanide) and pegylated interferon (PegIFN) alfa-2a in attaining sustained virologic response (SVR) in treatment of chronic hepatitis C (ERAIS-C Trial) in naive genotype 1 patients [J] . P.P.Basu, K.Rayapudi, T.Pacana, International journal of infectious diseases : . 2010,第Supplementa2期

机译：OL-002大剂量利巴韦林（RBV），异形症（Nitazoxanide）和聚乙二醇化干扰素（PegIFN）alfa-2a对初次基因型1型慢性丙型肝炎（ERAIS-C试验）的持续病毒学应答（SVR）的作用耐心
3. Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy. [J] . Ohno T Hepatology research: the official journal of the Japan Society of Hepatology . 2004,第2期

机译：基因型1b和高HCV RNA水平的慢性丙型肝炎患者每日高剂量IFNα-2b加利巴韦林治疗结果的预测：基线病毒水平与治疗期间和治疗后病毒动力学的关系。
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. Efficacy and Tolerability of Combination Therapy with Interferon-Alfa Plus Ribavirin in Patients with Chronic Hepatitis C Virus Infection: A Single-Center Study in Relapsers and Nonresponders to Previous Treatment with High-Dose Interferon-Alfa Monotherapy [O] . Federica Benini, Luciana Distefano, Ornella Baisini, 2003

机译：干扰素-阿尔法+利巴韦林联合治疗对慢性丙型肝炎病毒感染患者的疗效和耐受性：对复发者和无反应者的单中心研究以前对大剂量干扰素-阿尔法单药治疗
7. High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial). : High-Dose peg-IFN and Ribavirin and IL28B in HCV nonresponders [O] . Chevaliez, Stéphane, Hézode, Christophe, Soulier, Alexandre, 2011

机译：无反应性丙型肝炎患者的大剂量聚乙二醇化干扰素-α和利巴韦林及其与IL-28B基因型的关系（SYREN试验）。：HCV无应答者中的大剂量PEG-IFN和利巴韦林和IL28B

High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial). : High-Dose peg-IFN and Ribavirin and IL28B in HCV nonresponders

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅